文献速递复苏、休克与脓毒症中毒与环境急症

NACARDI决策工具:针对隐性阿片过量所致心脏骤停的靶向解毒治疗

NAloxone CARdiac Arrest Decision Instruments (NACARDI) for targeted antidotal therapy in occult opioid overdose precipitated cardiac arrest.
PubMed 文献 · Resuscitation · 2021-01-07
一句话结论在旧金山EMS接诊的767例院外心脏骤停死亡者中,10.4%为隐性阿片过量相关,作者推导出简单决策工具用于筛选可能受益于纳洛酮的患者。

该研究基于2011年2月至2017年12月旧金山县EMS接诊的院外心脏骤停死亡病例,所有病例均接受尸检和专家小组死因裁定。研究采用分类树分析推导预测隐性阿片过量相关心脏骤停的决策工具,并计算其筛查性能特征。767例中80例(10.4%)为隐性阿片过量相关。在8个灵敏度为100%的模型中,特异度最高的模型(23.4%,95%CI 20.3-26.7%)为年龄<60岁或种族为黑人/非拉丁裔白人或在公共场所发生骤停。特异度最高的工具(96.3%,95%CI 94.6-97.5%)由年龄<60岁且种族为黑人/非拉丁裔白人且无人目击骤停且女性组成,其灵敏度为25%(95%CI 16-35.9%)。作者认为这些工具可用于指导院外心脏骤停复苏中选择性给予纳洛酮。

要点

  • 767例院外心脏骤停死亡者中80例(10.4%)为隐性阿片过量相关,提示该病因在骤停人群中占一定比例。
  • 灵敏度100%的模型中特异度最高者(23.4%,95%CI 20.3-26.7%)为:年龄<60岁或种族为黑人/非拉丁裔白人或在公共场所发生骤停。
  • 特异度最高的工具(96.3%,95%CI 94.6-97.5%)为:年龄<60岁且种族为黑人/非拉丁裔白人且无人目击骤停且女性,灵敏度25%(95%CI 16-35.9%)。
  • 作者认为这些简单决策工具可用于指导院外心脏骤停复苏中选择性给予纳洛酮。

适用人群与场景

  • 旧金山县EMS接诊的院外心脏骤停死亡病例,均接受尸检和专家小组死因裁定,数据收集时间为2011年2月至2017年12月。

诊断标准与关键阈值

  • 灵敏度100%的模型中特异度最高者(23.4%,95%CI 20.3-26.7%)的筛选条件为:年龄<60岁或种族为黑人/非拉丁裔白人或在公共场所发生骤停。
  • 特异度最高的工具(96.3%,95%CI 94.6-97.5%)的筛选条件为:年龄<60岁且种族为黑人/非拉丁裔白人且无人目击骤停且女性,灵敏度25%(95%CI 16-35.9%)。

研究设计与关键结果

  • 研究类型为基于Postmortem Systematic Investigation of Sudden Cardiac Death研究的决策工具推导分析,样本为767例院外心脏骤停死亡者,其中80例(10.4%)为隐性阿片过量相关。
  • 在8个灵敏度为100%的模型中,特异度最高的模型特异度为23.4%(95%CI 20.3-26.7%),条件为年龄<60岁或种族为黑人/非拉丁裔白人或在公共场所发生骤停。
  • 特异度最高的工具特异度为96.3%(95%CI 94.6-97.5%),条件为年龄<60岁且种族为黑人/非拉丁裔白人且无人目击骤停且女性,灵敏度为25%(95%CI 16-35.9%)。

证据类型、等级与局限

  • 证据类型为基于尸检和专家裁定的决策工具推导研究,原文未报告证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些简单决策工具可用于识别院外心脏骤停患者中隐性阿片过量所致者,并指导复苏中选择性给予纳洛酮。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We have recently demonstrated that a significant proportion of fatal out-of-hospital cardiac arrests (OHCAs) are precipitated by occult overdose, which could benefit from antidote therapy administered adjunctively with other cardiac resuscitation measures. We sought to develop simple decision instruments that EMS providers and other first responders can use to rapidly identify occult opioid overdose-associated OHCAs.

METHODS: We examined data from February 2011 through December 2017 in the Postmortem Systematic Investigation of Sudden Cardiac Death study, in which San Francisco (California) County EMS-attended OHCA deaths received autopsy and expert panel adjudication of cause of death. Using classification tree analyses, we derived highly sensitive and specific decision instruments that predicted our primary outcome of occult opioid OD-associated OHCA. We then calculated screening performance characteristics of these instruments.

RESULTS: Of 767 OHCA deaths, 80 (10.4%) were associated with occult opioid overdose. Of the eight models with 100% sensitivity for opioid overdose-associated cardiac arrest, the highest specificity model (23.4%, 95% confidence interval [CI] 20.3-26.7%) was age < 60 years OR race = black or non-Latinx white OR arrest in public place. The highest specificity instrument (96.3%, 95% CI 94.6-97.5%) consisting of age < 60 years AND race = black or non-Latinx white AND unwitnessed arrest AND female sex had 25% (95% CI 16-35.9%) sensitivity.

CONCLUSIONS: We have derived simple decision instruments that can identify patients whose OHCA precipitant was occult opioid overdose. These instruments may be used to guide selective administration of the antidote naloxone in OHCA resuscitations.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Rodriguez RM, Tseng ZH, Montoy JCC, et al. NAloxone CARdiac Arrest Decision Instruments (NACARDI) for targeted antidotal therapy in occult opioid overdose precipitated cardiac arrest. Resuscitation. 2021. PMID: 33359417. doi:10.1016/j.resuscitation.2020.12.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。